FARALLON CAPITAL MANAGEMENT LLC Q4 2018 Filing
Filed February 14, 2019
Portfolio Value
$12.2T
Holdings
93
Report Date
Q4 2018
Filing Type
13F-HR
All Holdings (93 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 8,188,000 | $2.0T | 16.80% | Put |
| 2 | AABAUSDALTABA INC | 27,607,317 | $1.6T | 13.13% | |
| 3 | GOOGALPHABET INC | 464,405 | $480.9B | 3.95% | |
| 4 | METAFACEBOOK INC | 3,051,148 | $400.0B | 3.28% | |
| 5 | EQIXEQUINIX INC | 1,110,892 | $391.7B | 3.22% | |
| 6 | WABWABTEC CORP | 5,531,059 | $388.6B | 3.19% | |
| 7 | IQVIQVIA HLDGS INC | 3,219,308 | $374.0B | 3.07% | |
| 8 | CHTRCHARTER COMMUNICATIONS INC N | 1,080,481 | $307.9B | 2.53% | |
| 9 | VVISA INC | 2,319,726 | $306.1B | 2.51% | |
| 10 | TRUTRANSUNION | 5,268,739 | $299.3B | 2.46% | |
| 11 | BKNGBOOKING HLDGS INC | 165,482 | $285.0B | 2.34% | |
| 12 | —IHS MARKIT LTD | 5,920,016 | $284.0B | 2.33% | |
| 13 | ELVANTHEM INC | 1,050,000 | $275.8B | 2.26% | |
| 14 | MSFTMICROSOFT CORP | 2,588,874 | $263.0B | 2.16% | |
| 15 | GDGENERAL DYNAMICS CORP | 1,628,186 | $256.0B | 2.10% | |
| 16 | PLYAPLAYA HOTELS & RESORTS NV | 30,606,930 | $220.1B | 1.81% | |
| 17 | CICIGNA CORP NEW | 1,055,000 | $200.4B | 1.64% | |
| 18 | EFXEQUIFAX INC | 2,145,594 | $199.8B | 1.64% | |
| 19 | FISFIDELITY NATL INFORMATION SV | 1,899,355 | $194.8B | 1.60% | |
| 20 | SMHVANECK VECTORS ETF TR | 2,150,000 | $187.7B | 1.54% | Put |
| 21 | DELLDELL TECHNOLOGIES INC | 3,572,062 | $174.6B | 1.43% | |
| 22 | TLRYEURTILRAY INC | 2,479,515 | $162.1B | 1.33% | |
| 23 | VRSKVERISK ANALYTICS INC | 1,441,194 | $157.1B | 1.29% | |
| 24 | CTXSEURCITRIX SYS INC | 1,468,234 | $150.4B | 1.23% | |
| 25 | AZNASTRAZENECA PLC | 3,885,000 | $147.6B | 1.21% | |
| 26 | BABAALIBABA GROUP HLDG LTD | 1,050,000 | $143.9B | 1.18% | |
| 27 | LBTYBLIBERTY GLOBAL PLC | 5,972,437 | $127.5B | 1.05% | |
| 28 | —TESARO INC | 1,700,000 | $126.2B | 1.04% | |
| 29 | —ARRIS INTL INC | 3,580,000 | $109.4B | 0.90% | |
| 30 | LBTYBLIBERTY GLOBAL PLC | 4,937,202 | $101.9B | 0.84% | |
| 31 | ASNDASCENDIS PHARMA A S | 1,499,297 | $93.9B | 0.77% | |
| 32 | XLRNACCELERON PHARMA INC | 2,100,000 | $91.5B | 0.75% | |
| 33 | ARRYEURARRAY BIOPHARMA INC | 5,750,000 | $81.9B | 0.67% | |
| 34 | —MYOKARDIA INC | 1,600,278 | $78.2B | 0.64% | |
| 35 | —ZOGENIX INC | 2,050,500 | $74.8B | 0.61% | |
| 36 | —PANDORA MEDIA INC | 9,205,000 | $74.5B | 0.61% | |
| 37 | SRPTSAREPTA THERAPEUTICS INC | 640,000 | $69.8B | 0.57% | |
| 38 | ENTAENANTA PHARMACEUTICALS INC | 925,000 | $65.5B | 0.54% | |
| 39 | CVSCVS HEALTH CORP | 930,000 | $60.9B | 0.50% | |
| 40 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 1,450,000 | $59.5B | 0.49% | |
| 41 | MRTXEURMIRATI THERAPEUTICS INC | 1,300,000 | $55.1B | 0.45% | |
| 42 | IOVAIOVANCE BIOTHERAPEUTICS INC | 5,725,000 | $50.7B | 0.42% | |
| 43 | AMRNAMARIN CORP PLC | 3,500,000 | $47.6B | 0.39% | |
| 44 | GRFSGRIFOLS S A | 2,381,119 | $43.7B | 0.36% | |
| 45 | NVCRNOVOCURE LTD | 1,250,000 | $41.9B | 0.34% | |
| 46 | ALNYALNYLAM PHARMACEUTICALS INC | 550,000 | $40.1B | 0.33% | |
| 47 | EX9EXELIXIS INC | 2,000,000 | $39.3B | 0.32% | |
| 48 | RETAEURREATA PHARMACEUTICALS INC | 700,000 | $39.3B | 0.32% | |
| 49 | NXPINXP SEMICONDUCTORS N V | 535,000 | $39.2B | 0.32% | |
| 50 | SG7SAGE THERAPEUTICS INC | 400,000 | $38.3B | 0.31% | |
| 51 | CRSPCRISPR THERAPEUTICS AG | 1,250,000 | $35.7B | 0.29% | |
| 52 | FGENEURFIBROGEN INC | 750,000 | $34.7B | 0.28% | |
| 53 | —RADIUS HEALTH INC | 2,043,149 | $33.7B | 0.28% | |
| 54 | —BROOKFIELD PPTY PARTNERS L P | 2,075,000 | $33.4B | 0.27% | |
| 55 | RCREADY CAP CORP | 2,203,239 | $30.5B | 0.25% | |
| 56 | —ORBOTECH LTD | 535,721 | $30.3B | 0.25% | |
| 57 | FATEFATE THERAPEUTICS INC | 2,200,000 | $28.2B | 0.23% | |
| 58 | PTCTPTC THERAPEUTICS INC | 700,000 | $24.0B | 0.20% | |
| 59 | —PTC THERAPEUTICS INC | 24,130,000 | $23.6B | 0.19% | |
| 60 | —ZYMEWORKS INC | 1,575,000 | $23.1B | 0.19% | |
| 61 | CDXSCODEXIS INC | 1,155,000 | $19.3B | 0.16% | |
| 62 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,500,000 | $18.6B | 0.15% | |
| 63 | YB4PSAVARA INC | 2,425,000 | $18.4B | 0.15% | |
| 64 | DVAXDYNAVAX TECHNOLOGIES CORP | 2,000,000 | $18.3B | 0.15% | |
| 65 | BUDANHEUSER BUSCH INBEV SA/NV | 275,843 | $18.2B | 0.15% | |
| 66 | CLVSEURCLOVIS ONCOLOGY INC | 1,000,000 | $18.0B | 0.15% | |
| 67 | —PROGENICS PHARMACEUTICALS IN | 4,200,820 | $17.6B | 0.14% | |
| 68 | CCXIEURCHEMOCENTRYX INC | 1,450,000 | $15.8B | 0.13% | |
| 69 | —SHIRE PLC | 87,000 | $15.2B | 0.12% | |
| 70 | PTGXPROTAGONIST THERAPEUTICS INC | 2,199,674 | $14.8B | 0.12% | |
| 71 | —QUOTIENT LTD | 2,400,000 | $14.7B | 0.12% | |
| 72 | —BEMIS INC | 316,160 | $14.5B | 0.12% | |
| 73 | ILPTINDUSTRIAL LOGISTICS PPTYS T | 610,545 | $12.0B | 0.10% | |
| 74 | —APTINYX INC | 670,000 | $11.1B | 0.09% | |
| 75 | —AVROBIO INC | 650,000 | $10.8B | 0.09% | |
| 76 | CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC | 14,750,000 | $10.5B | 0.09% | |
| 77 | —ZEALAND PHARMA A S | 900,000 | $10.4B | 0.09% | |
| 78 | —PRINCIPIA BIOPHARMA INC | 350,000 | $9.6B | 0.08% | |
| 79 | —ZAFGEN INC | 1,775,000 | $8.8B | 0.07% | |
| 80 | —MELLANOX TECHNOLOGIES LTD | 95,000 | $8.8B | 0.07% | |
| 81 | VYGRVOYAGER THERAPEUTICS INC | 909,158 | $8.5B | 0.07% | |
| 82 | ASMBASSEMBLY BIOSCIENCES INC | 350,000 | $7.9B | 0.06% | |
| 83 | VOYAVOYA FINL INC | 185,000 | $7.4B | 0.06% | |
| 84 | —SYNTHORX INC | 386,092 | $6.7B | 0.06% | |
| 85 | —TRANSLATE BIO INC | 500,000 | $3.8B | 0.03% | |
| 86 | SNYSANOFI | 6,827,805 | $3.3B | 0.03% | |
| 87 | —BELLICUM PHARMACEUTICALS INC | 1,000,000 | $2.9B | 0.02% | |
| 88 | CRNXCRINETICS PHARMACEUTICALS IN | 95,365 | $2.9B | 0.02% | |
| 89 | ITCIEURINTRA CELLULAR THERAPIES INC | 250,000 | $2.8B | 0.02% | |
| 90 | AVAAVISTA CORP | 62,900 | $2.7B | 0.02% | |
| 91 | —PFENEX INC | 600,000 | $1.9B | 0.02% | |
| 92 | —TYME TECHNOLOGIES INC | 300,857 | $1.1B | 0.01% | |
| 93 | —RA MED SYS INC | 38,313 | $305.0M | 0.00% |